These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 33457253)

  • 1. The promising role of radiotherapy in the treatment of advanced or metastatic renal cell carcinoma: a narrative review.
    Wei Q; He H; Lv L; Xu X; Sun W
    Transl Androl Urol; 2020 Dec; 9(6):2821-2830. PubMed ID: 33457253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
    Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
    Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Stereotactic Ablative Body Radiotherapy in Renal Cell Carcinoma.
    Ali M; Mooi J; Lawrentschuk N; McKay RR; Hannan R; Lo SS; Hall WA; Siva S
    Eur Urol; 2022 Dec; 82(6):613-622. PubMed ID: 35843777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there a role for stereotactic radiotherapy in the treatment of renal cell carcinoma?
    Rühle A; Andratschke N; Siva S; Guckenberger M
    Clin Transl Radiat Oncol; 2019 Sep; 18():104-112. PubMed ID: 31341985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma.
    Raj RK; Upadhyay R; Wang SJ; Singer EA; Dason S
    Curr Oncol; 2023 Dec; 30(12):10283-10298. PubMed ID: 38132383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local control rates of metastatic renal cell carcinoma (RCC) to the bone using stereotactic body radiation therapy: Is RCC truly radioresistant?
    Amini A; Altoos B; Bourlon MT; Bedrick E; Bhatia S; Kessler ER; Flaig TW; Fisher CM; Kavanagh BD; Lam ET; Karam SD
    Pract Radiat Oncol; 2015; 5(6):e589-e596. PubMed ID: 26142027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC).
    Moreno-Olmedo E; Sabharwal A; Das P; Dallas N; Ford D; Perna C; Camilleri P
    Cancers (Basel); 2024 Jul; 16(15):. PubMed ID: 39123406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of primary and metastatic renal cell carcinoma (RCC) with image-guided stereotactic body radiation therapy (SBRT).
    Teh B; Bloch C; Galli-Guevara M; Doh L; Richardson S; Chiang S; Yeh P; Gonzalez M; Lunn W; Marco R; Jac J; Paulino A; Lu H; Butler E; Amato R
    Biomed Imaging Interv J; 2007 Jan; 3(1):e6. PubMed ID: 21614267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiation therapy to the kidney for metastatic renal cell carcinoma: A narrative review of an emerging concept.
    Hao C; Liu J; Ladbury C; Dorff T; Sampath S; Pal S; Dandapani S
    Cancer Treat Res Commun; 2023; 35():100692. PubMed ID: 36842365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic body radiotherapy (SBRT) for pulmonary metastases from renal cell carcinoma-a multicenter analysis of the German working group "Stereotactic Radiotherapy".
    Hoerner-Rieber J; Duma M; Blanck O; Hildebrandt G; Wittig A; Lohaus F; Flentje M; Mantel F; Krempien R; Eble MJ; Kahl KH; Boda-Heggemann J; Rieken S; Guckenberger M
    J Thorac Dis; 2017 Nov; 9(11):4512-4522. PubMed ID: 29268521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
    Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
    Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.
    Kothari G; Louie AV; Pryor D; Vela I; Lo SS; Teh BS; Siva S
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S17. PubMed ID: 28917255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative review.
    Turchan WT; Chmura SJ
    Ann Palliat Med; 2021 May; 10(5):6028-6044. PubMed ID: 33440982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spine stereotactic radiosurgery with concurrent tyrosine kinase inhibitors for metastatic renal cell carcinoma.
    Miller JA; Balagamwala EH; Angelov L; Suh JH; Rini B; Garcia JA; Ahluwalia M; Chao ST
    J Neurosurg Spine; 2016 Dec; 25(6):766-774. PubMed ID: 27391397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
    Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK
    Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study.
    Buti S; Bersanelli M; Viansone A; Leonetti A; Masini C; Ratta R; Procopio G; Maines F; Iacovelli R; Ciccarese C; Vitale MG; De Giorgi U; Mucciarini C; Maruzzo M; Prati G; Lattanzi E; Ciammella P; Bruni A; Andreani S; D'Abbiero N
    Cancer Treat Res Commun; 2020; 22():100161. PubMed ID: 31677494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time?
    Carrasco-Esteban E; Barrionuevo-Castillo P; Domínguez-Rullán J; Gómez-Aparicio MA; Ferri-Molina M; Sáez-Bueno P; Zalabarría-Zarrabeitia Z; Scorsetti M; Arcangeli S; López-Campos F; Couñago F
    Clin Oncol (R Coll Radiol); 2023 Mar; 35(3):163-176. PubMed ID: 36443137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer.
    Haque W; Verma V; Polamraju P; Farach A; Butler EB; Teh BS
    Radiother Oncol; 2018 Nov; 129(2):264-269. PubMed ID: 30031630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation Therapy in the Treatment of Localized and Advanced Renal Cancer.
    Yim K; Leeman JE
    Urol Clin North Am; 2023 May; 50(2):325-334. PubMed ID: 36948675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.